Old Web
English
Sign In
Acemap
>
Paper
>
Pomalidomide plus ruxolitinib in myelofibrosis: Updated results from the MPNSG-0212 trial
Pomalidomide plus ruxolitinib in myelofibrosis: Updated results from the MPNSG-0212 trial
2017
Frank Stegelmann
Markus Bangerter
M. Griesshammer
Holger Hebart
Regina Reim
K. Vetter
C. Scheid
Hartmut Doehner
Steffen Koschmieder
Thomas Kindler
Alfred Reiter
Denise Wolleschak
Florian H. Heidel
A. Hochhaus
Konstanze Doehner
R. Moehle
Ulrike Sutter
Nikolas von Bubnoff
Keywords:
Pathology
Alternative medicine
Pomalidomide
Physical therapy
Ruxolitinib
Myelofibrosis
Medicine
Pediatrics
Oncology
General surgery
Internal medicine
Correction
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]